We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results:1-10 of 496

New DOJ Guidance Policy Limits Use of Guidance Documents in Federal Civil Actions
  • Sheppard Mullin Richter & Hampton LLP
  • USA
  • February 20 2018

On January 25, 2018, Associate Attorney General Rachel Brand issued a memorandum on behalf of the U.S. Department of Justice (DOJ) (the “Brand

Capitol Hill Healthcare Update
  • Baker & Hostetler LLP
  • USA
  • June 5 2017

Senate Republicans return to Washington this week after a 10-day recess facing a key inflection point in their effort to repeal and replace the

New York Attorney General Announces Settlements with Three Mobile Health Application Developers
  • Jones Day
  • USA
  • May 12 2017

New York has made a mark on the regulatory and enforcement landscape for mobile health applications ("mobile health app") with the New York Attorney

New York Regulators Lead the Charge to Fill Health Data Protection Gaps Left by Federal Law
  • Hogan Lovells
  • USA
  • April 27 2017

After a year-long investigation into mobile health apps claiming to be able to measure vital signs or health indicators through smartphone sensors

HHS overhauls human subjects protection regulations
  • DLA Piper
  • USA
  • February 13 2017

The Department of Health and Human Services recently issued a final rule updating the requirements for all clinical research conducted or supported

Rand Corporation Issues Report on U.S. Blood System
  • Foley & Lardner LLP
  • USA
  • February 6 2017

“A robust, sustainable blood system is a crucial component of every health care system.” That is how Rand Corporation’s recently issued comprehensive

Stakeholder Agendas in the Washington Transition: 5 Takeaways for Converting Ideas into Technically Effective Proposals
  • Epstein Becker Green
  • USA
  • January 18 2017

As the transition in Washington moves into high gear this month, it’s not just the new Administration and Congress that are putting in place plans

Trump Administration: Impact on Healthcare Policy
  • Baker & Hostetler LLP
  • USA
  • November 17 2016

Republicans' biggest issue will be what to do with the 20 million Americans who have gained coverage under the ACA. Congress reconvened this week for

The DEA Is Getting Past Just Saying No: Scientific Research Into Medical Uses of Marijuana Is a Bridge Toward a Policy Shift
  • Lane Powell PC
  • USA
  • August 25 2016

The U.S. Drug Enforcement Agency (DEA)’s recent decision declining to reschedule cannabis is a step bridging the national discussion a step toward

Industrial Hemp - Statement of Principles from USDA
  • Husch Blackwell LLP
  • USA
  • August 25 2016

The US Department of Agriculture provided statements of principals on industrial hemp, in consultation with the DEA and the FDA, to inform the public